J.P. Morgan Securities LLC
BofA Securities, Inc.
UBS Securities LLC
SVB Leerink LLC
As Representatives of the
several Underwriters listed
in Schedule 1 to the Underwriting Agreement
c/o J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
c/o BofA Securities, Inc.
One Bryant Park
New York, New York 10036
c/o UBS Securities LLC
1285 Avenue of the Americas
New York, New York 10019
c/o SVB Leerink LLC
1301 Avenue of the Americas
New York, New York 10019
October 7, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | BioNTech SE |
Amendment No. 2 to Registration Statement on Form F-1
Filed October 4, 2019
File No. 333-233688
Request for Acceleration of Effective Date
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of BioNTech SE (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Time, on October 9, 2019, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Covington & Burling LLP and Freshfields Bruckhaus Deringer LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that approximately 1,500 copies of the Preliminary Prospectus included in the above-named Registration Statement, as amended, were distributed during the period from September 24, 2019 through the date hereof, to prospective underwriters, institutions, dealers and others.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
| Very truly yours, | ||
| Acting severally on behalf of themselves and the several Underwriters | ||
| J.P. MORGAN SECURITIES LLC | ||
| By: | /s/ David Ke | |
| Name: David Ke | ||
| Title: Executive Director | ||
| BOFA SECURITIES, INC. | ||
| By: | /s/ Michele A.H. Allong | |
| Name: Michele A.H. Allong | ||
| Title: Authorized Signatory | ||
| UBS SECURITIES LLC | ||
| By: | /s/ James Raul Stahlke | |
| Name: James Raul Stahlke | ||
| Title: Associate Director | ||
| By: | /s/ Robin Tang | |
| Name: Robin Tang | ||
| Title: Director | ||
| SVB LEERINK LLC | ||
| By: | /s/ Gabriel Cavazos | |
| Name: Gabriel Cavazos | ||
| Title: Managing Director | ||
[Signature Page to Underwriters’ Acceleration Request]